Looking for the role of cannabinoid receptor heteromers in striatal function
about
Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Adenosine-cannabinoid receptor interactions. Implications for striatal functionInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activationG protein-coupled receptor heterocomplexes in neuropsychiatric disorders.Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsCue-conditioned alcohol seeking in rats following abstinence: involvement of metabotropic glutamate 5 receptors.A putative 'pre-nervous' endocannabinoid system in early echinoderm development.Habit formation: implications for alcoholism research.Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severityDissociation of genetic and hormonal influences on sex differences in alcoholism-related behaviors.Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers.Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling.Pathophysiological roles for purines: adenosine, caffeine and urate.Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionLocal Control of Extracellular Dopamine Levels in the Medial Nucleus Accumbens by a Glutamatergic Projection from the Infralimbic CortexThe endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing.Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission.Label-free screening assays: a strategy for finding better drug candidates.Reward, interrupted: Inhibitory control and its relevance to addictions.Cannabis, a complex plant: different compounds and different effects on individuals.Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.Cannabinoids in Parkinson's DiseaseCannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical doseBivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice.
P2860
Q24630645-B5832B99-627F-40AD-9AF7-9AD24F3F39E3Q28286488-FCEAEFBF-8134-483B-877C-42BC6E04FF0BQ28298445-D3506E67-7EC6-4C03-97B4-4894AD6C4D36Q28728678-A546609F-0779-486C-902B-F4C4A0386F0FQ30385233-B3894A68-F2C9-406E-9397-49E5BFE94A51Q30475004-D4F028FE-5E96-4BC3-AFC3-485B0409DE1DQ33685890-504CF4C7-63DC-47B0-B9FF-5BD19AE6B3FEQ33837421-D3099786-8962-4EB3-9A85-6B0C6070C868Q33897637-7E22AA59-697B-4B44-8808-ABEC51D335DFQ34002281-5079DF24-7467-4EF3-8704-D1A07A84D034Q34064001-659CE5A6-AB83-47D7-BFFF-C810B1BDA561Q34094605-7C2DB902-3507-41EB-8E2F-5C531A7E6711Q34345068-8A9B9D8E-F9A9-4B04-8013-E7C3C6F29AD3Q35008049-CCA3DECE-094D-4BBB-99B5-9F8B3157F83BQ35046370-32D8CD62-85EE-4C21-9133-80BC020BE354Q35227731-A8B5E43A-3390-40E5-9B0F-60DF187F3784Q35489240-12ACB87B-A221-4E9F-9D01-7F482545EDC8Q35499568-E4FD29E5-7CFC-4220-82AC-5C5D38F5C9D4Q36480264-D85F6FC8-9326-4571-852C-B38FC5F7A77CQ36630516-B7464470-C266-4F11-9810-B84617551B34Q36924618-84F40AD3-0FFC-4531-BE5F-E06AB14BC041Q37856304-C033100E-4D8F-4DF3-919D-3EC04C88B629Q38113046-7F83D651-C0AC-467C-878D-A93967BAA16AQ38132167-1DDDFFB9-6207-47F3-8B6D-DFA47B4F1D2BQ38522769-56275776-A39D-4BF4-B308-E1CCF75C7451Q38604909-A584C66B-4E6F-4894-85B3-BA23C5DDA7DBQ38636791-54A65303-6BB2-4A16-81E6-618D2A83D779Q39359086-ED001E53-EA14-4075-BD4A-E8757B71E20FQ42258332-E36206C6-4B09-4A9C-99CB-5BA2A67077A6Q42320778-3BA5C840-BE8F-4A55-8DAB-EB126B8E08E0Q44348793-24442232-76A1-44E5-B1A5-9B4099FCF73E
P2860
Looking for the role of cannabinoid receptor heteromers in striatal function
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Looking for the role of cannabinoid receptor heteromers in striatal function
@ast
Looking for the role of cannabinoid receptor heteromers in striatal function
@en
Looking for the role of cannabinoid receptor heteromers in striatal function
@nl
type
label
Looking for the role of cannabinoid receptor heteromers in striatal function
@ast
Looking for the role of cannabinoid receptor heteromers in striatal function
@en
Looking for the role of cannabinoid receptor heteromers in striatal function
@nl
prefLabel
Looking for the role of cannabinoid receptor heteromers in striatal function
@ast
Looking for the role of cannabinoid receptor heteromers in striatal function
@en
Looking for the role of cannabinoid receptor heteromers in striatal function
@nl
P2093
P2860
P921
P1433
P1476
Looking for the role of cannabinoid receptor heteromers in striatal function
@en
P2093
Carme Lluis
Rafael Franco
Sergi Ferré
Steven R Goldberg
P2860
P304
P356
10.1016/J.NEUROPHARM.2008.06.076
P407
P478
56 Suppl 1
P577
2009-01-01T00:00:00Z